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One of the theories which explain, why gastroesophageal reflux disease (GORD) may provoke
cough, is the occurrence of aspiration of gastric content into the airways. The aim of the study
was to assess the presence of aspiration markers: pepsin and bile acids (BA) in induced sputum
in gastroesophageal reflux-related (GOR-related) chronic cough (CC) patients. Forty-one CC
patients and 20 healthy controls were enrolled in the study. GORD as cause of CC was diag-
nosed by presence of GORD-related symptoms, gastroscopy and/or improvement of cough
upon treatment with proton pump inhibitors (PPI). Patients were divided into two groups based
on the response to PPI treatment. In all patients and healthy controls induced sputum was ob-
tained and differential cell counts were calculated. Levels of pepsin and BA were measured in
sputum supernatants. Pepsin was detectable in 48.8% samples in CC patients and in 60%
healthy controls (p Z NS). In pepsin positive samples no significant difference in pepsin
concentration could be found between CC patients and control subjects. Pepsin levels in
pepsin positive samples were significantly decreased in patients treated with PPI compared
to non-treated patients. BA were detectable in 56% samples of CC patients and in 70% healthy
controls (pZ NS). BA concentration in BA positive samples in CC group was not different from
healthy controls. There was also no difference when comparing patients who took PPI and2225612.
.pl (M. Grabowski).
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1258 M. Grabowski et al.those who did not. Patients characterized as PPI-responders and PPI-non-responders had
similar pepsin and BA concentrations. Airway cellularity was not significantly different
between groups of patients with or without pepsin or BA in induced sputum. Our results
demonstrated the lack of differences in gastric content aspiration between patients with prob-
able GOR-related CC and healthy control subjects. This might imply that the reflex cough
theory may be more relevant than the reflux-associated aspiration theory in the pathophysi-
ology of GORinduced chronic cough.
ª 2011 Elsevier Ltd. All rights reserved.Introduction
It is well documented that gastroesophageal reflux disease
(GORD) and cough often coexist. Cough in subjects with
GORD can be evoked by two possible mechanisms:
a broncho-oesophageal neurogenic reflex, or aspiration of
gastric content into the airways (true “reflux” theory). The
microaspiration theory is supported by an observed fall in
tracheal pH following gastroesophageal reflux event and by
the presence of aspiration markers in bronchoalveolar
lavage fluid (BALF).1 Pepsin is a good marker of acidic
gastroesophageal reflux, and its presence in sputum or
saliva is considered to be pathologic. Its enzymatic activity
in spontaneous sputum and saliva might be a better test for
reflux-related aspiration than 24-h oesophageal pH moni-
toring and the pepsin assay could also be used to evaluate
reflux events without interrupting therapy with H2-blockers
or proton pump inhibitors (PPI).2 Bile acids aspiration has
been associated with pulmonary injury3 with dose-
dependent cytotoxicity ranging from alteration of cellular
cationic permeability to disruption of the cellular
membrane.
Sputum induction, sampling the central airways as a non-
invasivemethod to study airway inflammation and tomonitor
airway diseases, is well established and routinely used.
The aim of this study was to assess the ‘true reflux theory’
in chronic cough patients by studying the occurrence of
gastric content aspiration in the airways bymeasuring pepsin
and bile acids levels in induced sputum and assessing their
relationship with induced sputum cellularity.Table 1 Distribution of patients treated with PPI at the
time of sputum induction and their response to PPI.
Number of patients PPI response
Positive Negative
PPI at the time of
sputum induction
Yes 9 3 12
No 15 12 27
24 15Patients and methods
Study subjects were recruited between November 2009 and
February 2010 at the Department of Internal Medicine,
Geriatrics and Allergology of Wroclaw Medical University.
Patients referred to the outpatient clinic with a history of
chronic cough (lasting at least 8 weeks) were consecutively
included after signing informed consent. A diagnostic
protocol according to ERS guidelines was performed in all
patients.4 Patients with postnasal drip syndrome were
included if they had negative plain sinus radiography and
did not respond to previous treatment with topical corti-
costeroids or antihistaminics. Other exclusion criteria
were: (1) any abnormalities in chest radiograph, (2) asthma
(reversibility to bronchodilators or a positive histamine
provocation test), (3) smoking history of more than 5 pack-
years, (4) a respiratory infection within 4 weeks of inclu-
sion, or (5) cough induced by angiotensin convertingenzyme inhibitors (iACE). The control group consisted of
healthy non-smokers with negative allergic history, no
clinical symptoms of upper or lower airway disease, and no
typical GORD symptoms. Informed consent was obtained
from all study subjects. The study was approved by the
local Ethical Committee of Wroclaw Medical University,
Poland.
Forty one patients with chronic cough (11 males, mean
age 44 years (21e75y)) and 20 control subjects (7 males,
mean age 44 years (24e66 years)); p Z 0.72 and 0.74 for
sex and age respectively, were included.
Mean cough duration in patients was 3.9 years (0.5e20y).
Mean FEV1% predicted, FVC% predicted and FEV1/FVC in
patients were respectively 108.6% (84.7e136.8%); 105.3%
(79.6e123.0%) and 103.2 (87.0e117.4).
We first evaluated the presence of GORD in our study
subjects, based on the patient’s medical records and by
means of a detailed patient interview.
The presence of typical (heartburn, retrosternal pain,
belching) or atypical GORD symptoms, the results of
gastroscopy and details on the acid suppression treatment
were recorded. None of the subjects in the control group
revealed any GORD symptoms. At the time of sputum
induction 12 patients were already treated by PPI (ome-
prazole 40 mg or pantoprazole 80 mg daily) (see Table 1).
After sputum induction all patients were uniformly
treated with omeprazole 40 mg per day (n Z 39). The
response to PPI treatment was assessed 4 weeks later.
A positive response to PPI treatment was defined as
a partial or complete resolution of cough (n Z 15). When
cough did not improve sufficiently after at least 4 weeks
treatment with PPI, patients were scored to have a nega-
tive response to PPI (n Z 12).
Methodology of sputum induction, processing and cyto-
spin preparation has been published previously.5
Pepsin levels in sputum supernatants were measured by
ELISA kit (USCN Life Science Inc. Wuhan, China) by adding
the same concentration of DTT (0.1%) to the standard curve
samples as used in the sputum supernatants (detection limit
was 1.56 ng/ml). Total bile acids (TBA) concentration in






Chronic cough (n Z 41) 6.4  6.4 0.5  0.2
Healthy controls (n Z 20) 7.3  7.2 0.5  0.2
PPI treated at the time of
sputum induction (n Z 12)
8.6  6.8 0.4  0.2
PPI non-treated at the time
of sputum induction (n Z 27)
2.5  2.6 0.5  0.2
Reflux oesophagitis
(ROþ) (n Z 27)
6.7  7.6 0.5  0.3
Without reflux oesophagitis
(RO-) (n Z 10)
6.1  4.5 0.4  0.2
PPI responders (n Z 24) 5.8  5.6 0.5  0.3
PPI non-responders (n Z 15) 7.6  8.0 0.4  0.2
Figure 1 Pepsin concentration in pepsin-positive samples in
chronic cough patients, treated with PPI, not treated with PPI,
and healthy control subjects (a) and in samples negative and
positive for BA (b); as well as the percentage of neutrophils in
patients and healthy controls with or without detectable
pepsin in induced sputum (c). Sputum was induced in 41
patients with CC and 20 HC. Pepsin (a, b, c) and BA (b)
concentrations were measured by ELISA and enzymatic assay
respectively. White blood cells were counted on cytospin and
the proportion of neutrophils is represented in percentage (c).
In a and b, only pepsin-positive samples are represented.
PPI-responders are represented by closed symbols, non-
responders - by open symbols (a, b). The median is indicated
by a horizontal line. Comparisons were performed using two-
tailed ManneWhitney U-test (b) or KruskaleWallis test (a, c).
Pepsin and bile acids in induced sputum of chronic cough patientsv 1259sputum supernatants was analysed by enzymatic assay
(Bioquant, San Diego, USA) (detection limit was 0.2 mmol/L).
Data are presented as median and interquartile range,
or as mean and standard deviation, where appropriate.
Differences between the patients and controls were esti-
mated by Mann-Whitney-U or by the KruskaleWallis test
(for more than 2 groups). Correlations were verified by
Spearman correlation coefficients (r). A probability of
p < 0.05 was regarded as significant.
Results
In 37 out of 41 patients gastroscopy was performed. In 27/
37 patients reflux oesophagitis (RO) grade A (n Z 26) or
B (n Z 1) was diagnosed based on the Los Angeles classi-
fication.6 All 41 patients had at least one of the GORD-
related typical symptoms and aggravation of cough
accompanying activities resulting in lower oesophagus
relaxation, like change in posture, during/after meals, or
physical activity. The exclusion of other causes of cough
and the presence of oesophagitis, or typical symptoms
suggesting GORD in all of the CC patients included in our
study, suggests that all patients had a diagnosis of
gastroesophageal reflux-related cough (GOR-related
cough).
Positive response to PPI was diagnosed in 24 patients, 15
patients did not improve with PPI (“PPI-non-responders” or
“chronic idiopathic coughers (CIC)”, see Table 1). In
2 patients the response to PPI was not assessed. PPI
responders and non-responders (CIC) did not differ in age
(44.8 vs 42.5 years, p Z 0.7); gender (males: 8 vs 3,
p Z 0.6), duration of cough (3.6  5.0y vs 4.8  4.8y,
p Z 0.26) or lung function parameters: FEV1% predicted
(107.6%  11.1 vs 109.0%  15, p Z 0.9).
Pepsin was detected in 20 out of 41 (49%) sputum
samples from chronic cough patients and in 12/20
(60%) samples from healthy controls (p Z NS). In pepsin
positive samples (n Z 20), no significant difference in
pepsin concentration was observed between chronic cough
patients and control subjects (n Z 20) (p Z NS). Induced
sputum pepsin levels in pepsin positive samples were
significantly decreased in chronic cough patients treatedwith PPI at the time of sputum induction, when compared
to those chronic cough patients without PPI treatment or
healthy controls (p Z 0.018, Table 2, Fig. 1a). Pepsin
concentrations in induced sputum were not significantly
different between chronic cough patients with reflux
Table 3 Differential cell count in chronic cough patients (CC).
aCC, pepsinþ CC, pepsin HC p-value
Absolute Total cell count 3.3  1.8 2.6  1.5 3.8  2.5 0.26
Relativeb Epithelial cells % 37.6  17.5 40.7  14.9 47.9  17.0 0.52
Relativec Neutrophils % 32.3  23.8 27.2  14.5 36.0  19.8 0.43
Macrophages% 65.7  23.8 71.6  15.5 61.9  20.6 0.41
Eosinophils% 0.6  0.9 0.2  0.4 0.7  1.0 0.17
Lymphocytes% 1.5  1.5 0.9  1.2 1.5  1.1 0.12
Absolute Neutrophils 1.3  1.6 0.7  0.5 1.6  1.4 0.29
Macrophages 1.9  0.9 1.9  1.2 2.1  1.5 0.77
Eosinophils 0.02  0.03 0.006  0.01 0.02  0.04 0.17
Lymphocytes 0.05  0.06 0.02  0.02 0.06  0.07 0.13
a Chronic cough patients were subdivided into pepsin positive (pepsinþ) and pepsin negative (pepsin) patients, and compared to
healthy controls (HC). Comparison was done using KruskaleWallis test.
b Cytospins were prepared, 250 cells were counted and the percentage of epithelial cells was studied.
c Cytospins were prepared, 250 white blood cells were counted and the relative proportion of neutrophils, macrophages, eosinophils
and lymphocytes was studied.
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PPI-responders and PPI-non-responders e Table 2.
Low levels of BA were detected in 23 out of 41 (56%)
samples of chronic cough patients and in 14/20
(70%) samples of healthy controls (p Z NS). In BA-positive
samples, no significant difference in total bile acid
concentration was observed between chronic cough
patients and control subjects (pZ NS). In contrast to what
we observed for pepsin, BA levels did not vary between PPI
treated and untreated patients. As we observed for pepsin
measurements, sputum BA levels were comparable
between ROþ and RO- patients and between PPI responders
and non-responders, (see Table 2).
Pepsin concentrations tended to be higher in chronic
cough patients with BA in induced sputum: 8.8  7.3 vs.
4.0  4.4 ng/ml, respectively (p Z 0.059; Fig. 1b).
However, no significant correlation was found between BA
and pepsin levels in induced sputum (rZ 0.25, pZ 0.33).
Induced sputum differential cell count was not signifi-
cantly different between chronic cough patients and the
healthy control subjects, see Table 3. Similar results were
observed when comparing total and differential cell count
in patients with or without measurable pepsin in induced
sputum, although there was a trend towards increasing
percentages of neutrophils in induced sputum when sputum
pepsin was detectable (Fig. 1c).
Discussion
Patients with chronic cough, suspected to have gastro-
esophageal reflux with or without improvement of cough
upon PPI treatment, do not appear to have more features of
microaspiration than control subjects. In agreement with
these findings, no or very low levels of pepsin or bile acids
were detected in BAL or saliva in chronic cough populations
studied by Stavold et. al and Blondeau et al.3,7 The low
levels of pepsin in subjects/controls could partially be
affected by pretreatment with dithiothreitol (DTT), when
dissolving induced sputum. DTT has some protease activity
but the impact on pepsin has not been evaluated yet.8
Furthermore, Ervine and coworkers recently showed
significant increase of pepsin in saliva from healthy childrenafter sputum induction, which could be caused by the
procedure itself.9
In accordance to previous observations by Patterson
et al.,10 we found similar differential cell counts in induced
sputum samples from chronic cough patients with or
without measurable sputum pepsin or BA. In contrast,
studies by Carpagnano et al.11 demonstrated increased
neutrophilic airway inflammation in patients with GOR-
related chronic cough. Relative neutrophil counts in our
study also tended to be higher in pepsin-positive samples
obtained from both study and healthy subjects when
compared to pepsin-negative samples (Fig. 1c). Pepsin or
BA concentrations in induced sputum did not correlate with
age, duration of cough, spirometric parameters, or airway
cellularity (data not shown).
In conclusion our findings of similar pepsin and BA levels in
induced sputumof chronic cough patients and healthy control
subjects argue against the occurrence of significantly more
gastricmicroaspiration inGOR-related chronic cough patients
when compared to healthy controls. This was corroborated by
the absence of significant differences in pepsin and BA levels
when these patientswere compared on the basis of presence/
absence of reflux oesophagitis or response/nonresponse to
PPI. These findings do not exclude GORD as a potential cause
of chronic cough but suggest that the ‘cough reflex theory’
might be more relevant than the ‘reflux-aspiration theory’ to
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